FDA Provides Early Alert On Defibrillation Lead Issue From Boston Scientific
RefinitivThời gian đọc: dưới 1 phút
FDA:
FDA: PROVIDES EARLY ALERT ON DEFIBRILLATION LEAD ISSUE FROM BOSTON SCIENTIFIC
FDA: CERTAIN ENDOTAK RELIANCE DEFIBRILLATION LEADS WITH EXPANDED EPTFE COATED COILS MAY IMPACT SHOCK EFFICACY AND/OR REQUIRE EARLY REPLACEMENT
FDA: AS OF JULY 24, BOSTON SCIENTIFIC REPORTED 386 SERIOUS INJURIES, 16 PATIENT DEATHS ASSOCIATED WITH DEFIBRILLATION LEAD ISSUE- WEBSITE
Đăng nhập hoặc tạo tài khoản miễn phí trọn đời để đọc tin tức này